Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation. The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of the symptoms of the treatment of the syndrome require individualized development, usually including drug therapy, rehabilitation interventions, regular follow-up, etc.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immunodeficiency disorders that were previously difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely regimens according to changes in conditions. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of cardiac transmission of anti-synthetase syndrome.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.